Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Tech Press.
Press releases published on July 23, 2025
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
GlobeNewswire
·
July 23, 2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in …
Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
GlobeNewswire
·
July 23, 2025
ROCKVILLE, Md. and SUZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
·
July 23, 2025
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
GlobeNewswire
·
July 23, 2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously …
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs
GlobeNewswire
·
July 23, 2025
During the year ended April 30, 2025, net cash provided by financing activities was $10.4 million Stockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cash In May 2025, Alzamend dosed the first patient for the healthy human …
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product
GlobeNewswire
·
July 23, 2025
An Orphan Drug Designation Could Provide Significant Benefits to Regen SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provides further insight into its planned Phase 1 clinical trial of HemaXellerate, …
Remote Monitoring and Control Provider Acorn Approved for Listing on Nasdaq Capital Market
GlobeNewswire
·
July 23, 2025
WILMINGTON, Del., July 23, 2025 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for backup power generators, gas pipelines and air compressors, today announced that its common stock has been …
Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
GlobeNewswire
·
July 23, 2025
DUBLIN and BRIDGEWATER, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President …
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT
GlobeNewswire
·
July 23, 2025
HOUSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
GlobeNewswire
·
July 23, 2025
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously published estimates1 (3.9 per 100,000), which equates to …
NextGen Digital Platforms Inc. Appoints Mahyar Akhbari to the Advisor Board
GlobeNewswire
·
July 23, 2025
Vancouver, B.C., July 23, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased …
Bio Usawa Biotechnology and ServareGMP Form Strategic Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa
GlobeNewswire
·
July 23, 2025
KIGALI, Rwanda and SAN FRANCISCO and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd. (Bio Usawa) and ServareGMP (Servare) today announced a strategic partnership to establish advanced monoclonal antibody manufacturing capabilities …
BILT earns cybersecurity certification to support enterprise & government clients
GlobeNewswire
·
July 23, 2025
GRAPEVINE, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- BILT Incorporated, creators of the 3D Intelligent Instructions® platform, announced it has achieved ISO/IEC 27001:2022 certification, the globally recognized standard for information security management …
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
GlobeNewswire
·
July 23, 2025
- XIPERE Now Approved for Use in Multiple Global Markets - - Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector® - ALPHARETTA, Ga., July 23, 2025 (GLOBE …
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. …
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today …
FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
GlobeNewswire
·
July 23, 2025
FRIENDSWOOD, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its DecisionDx-Melanoma test has been granted Breakthrough …
Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
CertiK Skynet Report Ranks Leading Stablecoins: USDT, USDC, PYUSD, and RLUSD Among the Top
GlobeNewswire
·
July 23, 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- CertiK, the largest Web3 security services company, released its Skynet Stablecoin Spotlight Report for H1 2025, detailing the current state of the stablecoin market, how the Skynet Stablecoin Rating Framework …
CertiK Skynet 보고서, 스테이블코인 순위 발표 – USDT, USDC, PYUSD, RLUSD 상위권 차지
GlobeNewswire
·
July 23, 2025
뉴욕, July 23, 2025 (GLOBE NEWSWIRE) -- 글로벌 최대 Web3 보안 회사인 CertiK은《Skynet 2025년 상반기 스테이블코인 종합 보고서》를 발표했다. 이번 보고서는 스테이블코인 산업의 시장 성과, 리스크 환경, 규제 진행 상황 및 발전 추세를 체계적으로 정리하고 심층 분석한 내용을 담고 있다. 보고서의 순위에 따르면, USDT, USDC, PYUSD, RLUSD는 보안성, 시장 동향 및 규제 적합성 측면에서 우수한 …